Mr. Eelco Broersma became Chief Executive Officer of Eurodrug Laboratories in August 2017 after the acquisition of Eurodrug by Pacific Healthcare (Thailand). From January 2008 till July 2017, he has served as Chief Financial Officer while simultaneously overseeing the Supply Chain and Human Resources departments. During his years at Eurodrug Mr. Broersma has been actively involved in business development, successfully leading projects that have culminated in the international expansion Eurodrug’s business. Before joining Eurodrug, Mr. Broersma was Chief Financial Officer of Docs International (now Docs Global), an Executive Search company for the Healthcare industries, starting in 2002 and driving the European expansion of Docs until its successful sale by the Management Team to ICON plc in December 2007. During 2000 and 2001 he worked as a Consultant on the world wide divestment of Acordis Industrial Fibers (former Akzo Nobel). Mr. Broersma started his career in 1993 as an auditor at De Keijzer, Nipius & Co (now Crowe), serving many clients in the Life Sciences Industries as Account and Audit Manager untill 2001. He holds a degree in Business Economics from the University of Amsterdam.